Limnopharma
PrivateLast Round
Convertible Debt
Oct 5, 2022
Total Funding Raised
$320,000
Company Overview
Limnopharma is a pharmaceutical company that develops new therapies for retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Limnopharma Comps
Public and private peers based on sector, stage, and business model.
Limnopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Oct 5, 2022 | ||||
| Accelerator | Dec 23, 2021 | ||||
| Grant | Dec 20, 2020 | ||||
| Seed | Mar 1, 2019 |
Limnopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GENESIS Ventures | Series A, Seed |
| Center for Technological Development and Innovation | Grant |
| AcexHealth | Accelerator |
| Medex Partners | Series A |
| La Fondation de l'Avenir | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 5, 2022
Raised funding from Covirán S.C.A.
- Dec 23, 2021
$10K round led by AcexHealth
Limnopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Limnopharma's valuation, stock price, and market status.
